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The ability of an organism to distinguish self from nonself is determined by a cluster of genes 
located in the major histocompatibility complex. Recent advances in molecular genetics and cellular 
immunology have begun to elucidate the mechanisms responsible for immune response regulation. In 
this review article, the genetic organization of the murine and human major histocompatibility 
complexes and the manner by which their gene products modulate immune responsiveness are 
discussed. 0 1985 Academic Press. Inc. 
INTRODUCTION 
The body’s recognition of a foreign sub- 
stance as nonself initiates a complex cascade 
of events which leads to an immune response. 
Regulation of this immune response is con- 
trolled by a cluster of tightly linked genes 
encoded within the major histocompatibility 
complex (MHC) [ 1, 21. While the MHC was 
originally defined as the site for control of 
graft rejection, it is now known that MHC 
genes have a variety of functions including 
immune response regulation, complement 
component synthesis, viral and tumor im- 
munity, and cell-cell interactions [3-51. The 
direct relationship between immune compe- 
tence and survival may account for why this 
genetic region has been so highly conserved 
over the course of evolution and is present 
in remarkably similar forms in all vertebrate 
species [6]. 
Originally, surgeons and immunologists 
were interested in the MHC because of its 
important role in organ graft rejection. 
Largely through efforts directed at avoiding 
graft rejection by manipulating the MHC, 
the general role of MHC molecules in the 
immune response to foreign antigens became 
more clearly understood. Recent investigation 
has demonstrated that MHC molecules reg- 
ulate the immune response in several ways. 
Whether this regulation is their primary 
function is not clear, as it seems possible that 
other as yet undiscovered levels of regulation 
of the immune response may exist. Since 
much of our understanding of the role of the 
MHC in immune regulation has resulted 
from studies on the mouse MHC, the struc- 
ture and function of both mouse and, when 
available, human MHC molecules will be 
discussed in this review. Our emphasis will 
be on the role the MHC genetic locus plays 
in the establishment, maintenance, and de- 
fense of self. 
The MHC Genes and Their Products 
The murine major histocompatibility genes 
are contained within 2.0 centimorgans (4000 
kilobases) of DNA on chromosome 17 [7, 
81. This H-2 MHC consists of five distinct 
gene clusters representative of three different 
gene families (Fig. 1). The class I molecules, 
formerly termed the major transplantation 
antigens, are encoded in the H-2K and H- 
2D/L gene clusters which flank the class II 
and III genes on either side [9]. The class I 
molecules have been implicated in graft re- 
jection, cell-mediated lympholysis reactions, 
and viral and tumor immunity [lo]. The 
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serologic polymorphism, and function. The 
K D/L Qa/TLa class I genes contained in the H-2K and H- 
~rlHl-cm”~0 ,000000- 2D/L clusters encode the highly polymorphic 
FIG. I. Genetic organization of the murine major transplantation molecules found on the cell 
histocompatihility complex (H-2). The properties of the surface of most nucleated cells. These class I 
class I (D), class II (0) and class III (El) gene products molecules play important roles in T-cell rec- 
are described in the text. ognition of viral or tumor antigens on infected 
and transformed cells. In addition, the H- 
2K, D, and L molecules are involved in 
class II genes, or immune response (Zr) genes, cytotoxic T-cell killing and allograft rejection. 
important in the generation of immune re- The second category of class I genes in- 
sponses to protein antigens, are located in cludes the Qa-2,3, TLa, and Qa-I which 
the Z region and code for the immune re- encode for less polymorphic molecules pres- 
sponse-associated (Ia) antigens [7, 111. The ent on certain hematopoietic cells. The func- 
class III genes which encode some of the tion of these molecules is not known [20]. 
complement component polypeptides are Whereas some of the TLa genes code for 
contained in the H-2s locus [ 121. Finally, hematopoietic differentiation antigens found 
distal to the class I, II, and III genes, located on thymocytes early in development and on 
in the Qa, TLa region, is a cluster of 20-30 leukemic cells, the Qa antigens are located 
related genes, similar to the class I genes, on many different types of lymphoid cells 
which code for differentiation antigens ex- [21-231. The DNA sequence of these TLa 
pressed on certain hematopoietic cells [ 13, 141. and Qa genes has been shown to exhibit 
The class I histocompatibility molecules striking homology to the class I transplanta- 
are composed of two noncovalently associated tion molecules. Moreover, Qa-2,3 genes from 
polypeptide chains: a highly polymorphic different mouse strains are as homologous to 
45,000-Dalton glycoprotein coded for by the the genes encoding the transplantation mol- 
MHC H-2K, H-2D/L genes and an 11,600- ecules as they are to one another [24]. 
Da non-MHC-coded protein of limited vari- The class II molecules are encoded by the 
ability termed p2 microglobulin (Fig. 2A) [ 15, Z region of the murine MHC [25]. The Z- 
161. These molecules are expressed on the region genes include the A/3, Aa, EP, and Ea 
membrane of all cells, but are more densely genes which code for the four polypeptides 
concentrated on lymphocytes [ 171. The class that form the Aa:A@ (I-A) and Ea:EP (I-E) 
I H-2K glycoprotein is composed of 346 molecules expressed on the surface of B 
amino acid residues and two carbohydrate lymphocytes, dendritic cells, and macro- 
moieties [ 181. On the basis of its postulated phages (Fig. 2B) [26, 271. The (Y chains range 
structure in the cell surface membrane, the 
molecule can be divided into three external 
domains of approximately 90 amino acids 
(A) 
each, one hydrophobic transmembrane por- 
(B) B 
tion, and a hydrophilic intracellular region 
at the extreme carboxy terminus. The greatest 
region of class I molecule polymorphism is 
concentrated within the outermost external 
domain [ 191. This may be important in the 
recognition of foreign class I glycoproteins as 
nonself by cytotoxic T lymphocytes. FIG. 2. Schematic representation of the major histo- 
The molecules encoded by the class I genes compatibility complex gene products. (A) Class I molecule 
fall into two categories by virtue of their 
with its three external domains associated with &mi- 
differences in cellular distribution, extent of 
croglobuhn. (B) Class II molecule composed of one 01 
and one fl chain each with two external domains. 
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in molecular mass from 30,000-33,000 Da 
and contain two carbohydrate moieties while 
the B chains contain only one carbohydrate 
group and range in molecular mass from 
27,000-29,000 Da [28]. Each class II poly- 
peptide is composed of two external domains 
of about 90 amino acid residues in length, a 
transmembrane region, and a short cyto- 
plasmic portion [29]. In contrast to the class 
I molecules where one chain (p2 microglob- 
ulin) does not insert into the membrane, 
both class II (Y and p chains are transmem- 
brane structures. By comparison of amino 
acid and nucleotide homologs between the (Y 
and fi chains, the cy chains have been shown 
to be more tightly conserved whereas the /3 
chains are more polymorphic [30]. This /3- 
chain polymorphism may be important in 
the recognition of class II molecules in the 
generation of immune responses to foreign 
antigens. 
The Function of MHC Molecules 
Earlier studies on the organization of the 
murine MHC have referred to Zr genes, 
subregions, and loci which regulate the im- 
mune response and restrict T-cell interactions 
[3 11. With recent advances in molecular ge- 
netics, this nomenclature has been altered to 
reflect the expression of physical genes located 
in the MHC. Therefore, the assignment of Zr 
genes to subregions and loci within the H-21 
region has evolved into the notion that foreign 
antigens associate with determinants (epi- 
topes) expressed on the I-A or I-E molecules 
to form complexes which can be recognized 
by T cells to initiate the cascade of events 
culminating in cell-mediated and antibody- 
mediated immunity [32, 331. In this fashion, 
immune responses to protein antigens are 
genetically restricted. 
The manner by which the class I and II 
molecules regulate the immune response has 
been the subject of many recent articles [34, 
351. Although this issue has been extensively 
investigated, the mechanisms of regulation 
are far from completely understood. Whereas 
some investigators view the class I or class II 
molecules as “restricting” the T-cell response 
to viral or protein antigens [36, 371, others 
claim that the diversity in immune response 
patterns resides in the T-cell repertoire and 
is independent of the expression of class I or 
II gene products [38, 391. Most probably, the 
immune response patterns observed in any 
given individual result from a combination 
of class I and II molecules and T-cell reper- 
toire contributions. 
Among the functions regulated by the class 
I molecules are graft rejection, viral and 
tumor immunity, and cell-mediated lympho- 
lysis (CML) reactions. Recognition of foreign 
class I molecules on donor tissue cells by the 
host immune system results in profound 
graft rejection mediated by both humoral 
and cellular pathways. Class I molecules have 
been shown to play a role in the immune 
response to viral and tumor-associated anti- 
gens by forming complexes which can be 
recognized by T lymphocytes 1401. Triggering 
these T lymphocytes results in lysis of cells 
expressing this complex. Finally, CML reac- 
tions are regulated by class I molecules, in 
that recognition of foreign class I molecules 
by the host immune system culminates in 
the generation of cytolytic T lymphocytes. 
This assay is used clinically to detect class I 
molecule incompatibilities between graft do- 
nor and recipient. 
Class II immune response-associated mol- 
ecules have been shown to regulate the inter- 
actions between macrophages, T cells, and B 
cells necessary for the generation of immune 
responses to foreign antigens [41, 421. 1 hese 
Ia molecules form complexes with processed 
foreign antigen on the surfaces of macro- 
phages and B cells [35] which when recog- 
nized by T lymphocytes allow for the estab- 
lishment of cellular- (T lymphocyte) and 
antibody- (B lymphocyte) mediated immune 
reactions [43, 441. In order for the T cells to 
perform their effector functions, they must 
recognize foreign antigen in the context of a 
class I or class II molecule; this recognition 
in association with an MHC molecule is 
termed H-2 restriction. Recognition of the 
same foreign antigen in the context of a 
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different class I or class II molecule will not 
trigger the T cells to initiate an immune 
response. 
The ability to initiate the cascade of events 
culminating in cell-mediated and antibody- 
mediated immune reactions depends upon 
successful interactions between macrophages 
(antigen-presenting cells) or target cells and 
T lymphocytes. This interaction requires rec- 
ognition by specific receptors on T lympho- 
cytes of processed protein antigens or viral 
antigens in association with class II and class 
I molecules, respectively [45]. Failure to ini- 
tiate T-lymphocyte proliferation can result 
from an unsuccessful macrophage/target cell- 
T-lymphocyte interaction either due to (1) 
the lack of appropriate T lymphocytes in the 
T-cell repertoire to recognize the macrophage/ 
target cell MHC molecule + antigen complex 
[46, 471, (2) the inability of the macrophage/ 
target cell to form the required complex 
necessary to trigger T-cell proliferation [48], 
or (3) specific immune suppression [49, 501. 
In many cases of nonresponsiveness, it is 
difficult to determine whether nonrespon- 
siveness is due to a defect in the macrophage/ 
target cell or the T-cell repertoire. 
There are certain immune responses to 
antigens for which suppression has been 
demonstrated to account for nonresponsive- 
ness. The failure of certain mouse strains to 
respond to some polypeptide antigens [5 1, 
521 is clearly due to the activation of sup- 
pressor T lymphocytes whereas nonrespon- 
siveness to other proteins is the result of 
concurrent activation of helper T cells by the 
I-A molecule + antigen complex and sup- 
pressor T cells by the I-E molecule + antigen 
complex [53]. In cases of nonresponsiveness 
where no T-cell suppressor activity has been 
detected to account for the failure to initiate 
an immune response, the defect is localized 
to the level of the macrophage/target cell-T- 
lymphocyte interaction [54]. The two per- 
spectives on this issue differ primarily in their 
assignment of the level of the immune re- 
sponse defect-the “determinant selection- 
ists” argue that nonresponder macrophagesl 
target cells fail to present antigen in an 
immunogenic form to responding T cells 
[37] whereas others claim that no antigen- 
presenting cell defect exists in nonresponders, 
but rather that nonresponsiveness results from 
holes in the T-cell repertoire due to T-cell 
deletions during immunological maturation 
[55-571. To date, no experiments have been 
performed which unambiguously resolve this 
conflict. 
Functional Pleiomorphism of 
MHC Products 
According to the traditional model, the 
MHC is a chromosomal segment which con- 
tains a number of regions, subregions, and 
loci coding for different immunologic traits. 
This concept of separate loci, each controlling 
distinct traits, has been recently replaced by 
the idea that the phenotypic expression of 
each individual MHC gene is pleiomorphic 
in that a single MHC gene product can 
modulate several functions [ 11. Therefore, 
immunologic traits such as allografi rejection, 
cell-mediated lympholysis, mixed lymphocyte 
reactivity, and regulation of T-cell activation 
all represent different manifestations of the 
same MHC molecules. The different mani- 
festations arise from the activation of distinct 
subsets of effector T lymphocytes, each ca- 
pable of different effector functions. Whereas 
recognition of a foreign transplantation mol- 
ecule leads to the generation of cell-mediated 
lympholysis by the activation of cytotoxic T 
lymphocytes, the same molecule can evoke 
allograft rejection through the recruitment of 
other T-lymphocyte subsets. 
The ability of a single gene product to 
regulate a seemingly diverse set of reactions 
can be explained in the following manner: 
The recognition of any foreign antigen, 
whether it be a soluble polypeptide, MHC 
molecule, or MHC molecule associated with 
viral/tumor antigens, requires the activation 
of helper T lymphocytes. These helper T 
cells are turned on by antigen-presenting cells 
(macrophages) which express membrane 
complexes composed of self-class II molecules 
and processed foreign antigen. Once triggered, 
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these “common denominator” lymphocytes 
can activate cytolytic T lymphocytes resulting 
in the destruction of target cells expressing 
that foreign antigen. Alternatively, they can 
activate other helper T or B lymphocytes to 
trigger the events which culminate in an 
antibody-mediated immune response [58, 591. 
All of these reactions probably occur simul- 
taneously but the ability to dissect out the 
individual interactions is biased by the assay 
system employed. The induction of a CML 
reaction by host cytolytic T lymphocytes 
does not preclude the generation of a mixed 
lymphocyte reaction in the same test tube; it 
is only that the detection system used focuses 
attention on a single reaction. 
A Model of MHC-Restricted Immune 
Responsiveness 
One hypothesis to account for the nature 
of nonresponsiveness would propose that the 
role of the class I and II molecules are to 
direct the establishment of the T-cell reper- 
toire. This is not to suggest that these mole- 
cules do not provide the context for recog- 
nition of foreign antigens, but rather that 
their primary role is to instruct the maturing 
immune system as to which T-cell clones 
must be eliminated to prevent self-destruc- 
tion. Based on this hypothesis, nonrespon- 
siveness to antigen X in a particular mouse 
strain would result from the elimination of 
T-cell clones which recognize the self-I-A 
molecule + antigen-X complex, presumably 
due to the resemblance between the complex 
formed by the association of the self-I-A 
molecule + antigen-X and some other self- 
determinant expressed in the developing 
mouse [60-621. Supportive evidence for this 
suggestion comes from studies in which mice 
have been neonatally tolerized to foreign 
antigens [63-641. This model would predict 
that the failure of the neonatally tolerized 
mice to respond to that foreign antigen later 
in adult life is due to the elimination of that 
clone of T cells reactive to the self-I-A mol- 
ecule + foreign antigen complex during the 
establishment of the T-cell repertoire. Other 
studies demonstrating the existence of T-cell 
clones with dual reactivity for self-MHC mol- 
ecules + antigen and nonself-MHC molecules 
lend credence to this argument [65]. The 
attractiveness of this model is that it combines 
both antigen-presenting cell defects and holes 
in the T-cell repertoire to account for non- 
responsiveness. 
Inasmuch as the number of class II mole- 
cules appears to be limited (perhaps two in 
mice and six in man), the tremendous 
amount of diversity observed must be created 
by other means. To begin with, the entire 
extracellular portion of the class II molecule 
is available for associations with processed 
antigens. Studies using monoclonal antibodies 
and T-cell clones suggest that there exist 
multiple distinct determinant clusters on each 
class I and class II molecule and that these 
individual sites may be used to activate dif- 
ferent populations of T cells in the response 
to foreign antigens [66]. Furthermore, the 
ability of the class II molecule (Y and p chains 
to freely associate in a heterozygous mouse 
creates four hybrid class II molecules in 
addition to the original four parental ones 
[67]. It has been shown that MHC hetero- 
zygotes have an additional level of immune 
response diversity due to the recognition of 
foreign antigens in the context of unique 
hybrid class II molecules unavailable in the 
original parents [68]. The number of discrete 
class II molecules which could be created in 
any typical heterozygous human being with 
three cy and three p chains would be 36. 
Assuming that each molecule expressed at 
least three distinct determinant clusters for 
association with antigen brings the total 
number of possible associations with any 
given processed antigen to well over 100. 
This conservative figure suggests that the 
avenues for the creation of immune response 
diversity with a limited number of class II 
molecules are potentially great. Other mech- 
anisms for the creation of immune response 
diversity include mutation, genetic recombi- 
nation, and gene conversion involving the 
MHC genes [69-711. The extent to which 
these are operative in nature is not known. 
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The Human Major Histocompatibility MLR-defined specificities is not clearly de- 
Complex termined. 
There is considerable data from many 
The major histocompatibility complex in investigators that demonstrate that the struc- 
man, although similar to that described for ture and function of the human class II 
the mouse H-2 complex, has proven more molecules are identical to their mouse ho- 
difficult to study. Located on chromosome mologs [74-761. Presentation of defined pro- 
6, the HLA complex encompasses about 3 tein antigens by human mononuclear cells 
centimorgans of DNA (6000 kilobases) and to immune T lymphocytes can be inhibited 
contains at least three class I and three class with anti-HLA-D/DR sera, illustrating the 
II gene loci which code for immune polypep- requirement for human class II molecules in 
tides homologous to the transplantation an- the activation of antigen-reactive T cells. 
tigens and immune response-associated mol- Some of the defined human class II molecule 
ecules in the mouse (Fig. 3) [72]. The HLA- specificities have been associated with altered 
D/OR region, analogous to the I region of immune response capabilities in normal in- 
the mouse, is located between the centromere dividuals [77] as well as with the ability to 
and the HLA-A, B, and C class I loci. It has respond to certain antigens [78]. Lastly, cor- 
been shown to consist of a number of closely relations have been found between particular 
related genes which code for a series of (Y HLA-D/DR alleles and a variety of human 
(33,000 molecular weight) and /3 (28,000 diseases, suggesting that the products of these 
molecular weight) polypeptide chains that genetic loci play important and varied roles 
comprise the class II molecules. The mini- in disease susceptibility. 
mum number of class II genetic loci and A number of serologically-detected speci- 
molecules in humans is three: HLA-DR which ficities have also been associated with the 
codes for proteins homologous to the murine HLA-D/DR region [79]. These include the 
I-E class II molecules, HLA-DS which en- MB and MT series which are found to be 
codes class II molecules with striking homol- strongly associated with certain defined HLA- 
ogy to the murine I-A molecules, and HLA- D/OR specificities. For example, the MT-l 
SB for which no murine homolog has been specificity defined by alloantiserum has been 
identified [73]. Each locus codes for its own localized to HLA-DS molecule determinants 
set of CY and p chains. HLA-D/DR gene which are closely linked to certain HLA-D/ 
products have been identified by mixed lym- DR molecule determinants. On the other 
phocyte reaction analysis (HLA-D) as well as hand, the serologically defined MT-2 speci- 
by serological methods using alloantisera ficity detects determinants present on both 
(HLA-DR). HLA-SB gene products were HLA-DS and HLA-D/DR molecules and is 
originally detected by mixed lymphocyte re- therefore termed a “supertypic specificity.” 
action and later by serological analysis. The Further study will begin to elucidate the 
relationship between these serologically and relationships between these specificities and 
defined molecular epitopes on human class 
II molecules. 
sB /D\ “c’4 
The class I HLA-A, B, and C genes code 
for the major transplantation antigens which, 
DR DS Bf B C A along with human fi2 microglobulin, are ex- 
-n-m-Lx-%- pressed on the surface of all cells [80]. As 
FIG. 3. Genetic organization of the human major 
with the human class II molecules, the struc- 
histocompatibility complex (ZfL4). The properties of the ture and function of the human class I mol- 
class I (m), class II (O), and class III (0) gene products ecules are identical to their mouse homologs 
are described in the text. The exact order and number [8 1, 821. Functional studies investigating the 
of DRl DS LY and @ genes are not known to date. contribution of human class I and class II 
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molecules to genetic regulation of the im- 
mune response have not progressed as rapidly 
as they have in the mouse. However, recent 
advances in molecular biology which allow 
the introduction and expression of cloned 
chromosomal HLA genes in mouse fibroblast 
cells provide the experimental system neces- 
sary to address these functional questions [83]. 
Overview of MHC-Mediated Functions 
In discussing the genetic control of the 
immune response, it is important to consider 
the gene families on the murine chromosome 
17 in a unified manner. Four gene families 
reside on this chromosome and their associ- 
ation is conserved from species to species 
[84]. These gene families, the T/t, TLa/Qa, 
class I transplantation, and class II immune 
response gene clusters, are related to one 
another in that they all provide cell surface 
recognition structures required for cell-cell 
interactions. The T/t gene complex located 
upstream from the H-2 complex encodes a 
series of codominantly expressed antigens 
which operate as mediators of cell-cell rec- 
ognition in the early developing embryo [85, 
861. These t antigens are found in the early 
embryo and not on adult tissues, with the 
exception of sperm and certain teratomas, 
and associate with p2 microglobulin as class 
I molecules do. When homozygously ex- 
pressed, t mutants result in dramatic cell- 
cell interaction defects which lead to prema- 
ture death of the developing embryo. The 
assumption is that these mutations specify 
abnormal cell surface components both on 
sperm and on embryonic cells. In the case of 
embryonic cells, T-locus products appear se- 
quentially and transiently and may govern 
processes necessary for cell-cell communi- 
cation during the early stages of embryogen- 
esis. 
These clusters of related genes may repre- 
sent a “supergene” family which code for 
molecules important in cell-cell interactions: 
The T-locus molecules provide cell surface 
elements necessary for the establishment of 
self during early embryogenesis and are later 
replaced by the class I and II molecules 
which continue to provide cell surface mark- 
ers of self into adult life [87]. Although the 
functions of the TLa and Qa antigens have 
not been determined, it is likely that they 
also serve as cell surface recognition structures 
for cell-cell communication. 
The similarities between these four gene 
families are suggestive of the existence of a 
supergene family which provides a series of 
self markers to be used as recognition struc- 
tures in a surveillance system designed at 
maintaining self [84]. Whereas the class I 
and class II molecules are part of an immune 
surveillance system aimed at distinguishing 
between self and nonself after the establish- 
ment of self, the T-locus molecules may 
represent cell surface structures expressed 
transiently and sequentially in the establish- 
ment of self early in embryogenesis. Insomuch 
as the adult faces a foreign environment that 
is constantly changing, the developing embryo 
creates an internal milieu which is constantly 
in flux and becomes foreign to its previous 
self as it matures. The manner by which this 
supergene family exerts its influence on the 
establishment, surveillance, and maintenance 
of self is critical to an understanding of the 
basic processes of life [88]. A better appreci- 
ation of these mechanisms may provide in- 
sights into clinical solutions for the correction 
of autoreactive diseases and developmental 
abnormalities. 
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